Craig Wilson
Stony Brook Medicine(US)Northport VA Medical Center(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer, Peptidase Inhibition and Analysis, Heart Failure Treatment and Management
Most-Cited Works
- → Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes(2013)2,508 cited
- → Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial(2015)751 cited
- → Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control(2008)224 cited
- → EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE)(2011)150 cited
- → Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study(2009)132 cited
- → Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes(2010)111 cited